4Koras O, Bozkurt IH, Yonguc T, et al. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study [J]. Urolithiasis, 2014, [Epub ahead of print].
5Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy[J]. Urol Int, 2011, 86(4): 448-452.
6Moslemmi MK, Mousavi-Bahar SI-I, Abedinzadeh M. The feasibility of regional anesthesia in the percutaneous nephrolithotomy with supracostal approach and its comparison with general anesthesia [J]. Urolithiasis, 2013, 41(1): 53-57.
7Cadeddu JA, Chen R, Bishoff J, et al. Clinical significance of fever after percutaneous nephrolithotomy[J]. Urolog, 1998, 52(1): 48-50.
8Deitch EA, Goodman ER. Prevention of multiple organ failure [J]. Surg Clin North Am, 1999, 79(6): 1471-1488.
9Kimura H,?Okada O,?Tanabe N, et al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension[J]. Am J Respir Crit Care Med, 2001, 164(2): 319-324.
10Ozova EM, Kiiakbaev GK, Kobalava ZhD. Inflammation and chronic heart failure.The role of statins [J]. Kardiologiia, 2007, 47 (1): 52-64.
